Implementation of the national Getting it Right First Time orthopaedic programme in England: a qualitative case study analysis.

Adult orthopaedics Orthopaedic & trauma surgery QUALITATIVE RESEARCH Quality in health care

Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
24 02 2023
Historique:
entrez: 24 2 2023
pubmed: 25 2 2023
medline: 3 3 2023
Statut: epublish

Résumé

To describe the implementation and impact of the Getting it Right First Time (GIRFT) national orthopaedic improvement programme at the level of individual National Health Service (NHS) Trusts. Qualitative case studies conducted at six NHS Trusts, as part of a mixed-methods evaluation of GIRFT. NHS elective orthopaedic surgery in England. 59 NHS staff. Improvement bundle, including bespoke routine performance data and improvement recommendations for each organisation, delivered via 'deep-dive' visits to NHS Trusts by a senior orthopaedic clinician. Although all case study sites had made improvements to care, very few of these were reportedly a direct consequence of GIRFT. A range of factors, operating at three different levels, influenced their ability to implement GIRFT recommendations: at the level of the orthopaedic team (micro-eg, how individuals perceived the intervention); the wider Trust (meso-eg, competition for theatre/bed space) and the health economy more broadly (macro-eg, requirements to form local networks). Some sites used GIRFT evidence to support arguments for change which helped cement and formalise existing plans. However, where GIRFT measures were not a Trust priority because of more immediate demands-for example, financial and bed pressures-it was less likely to influence change. Dynamic relationships between the different contextual factors, within and between the three levels, can impact the effectiveness of a large-scale improvement intervention and may account for variations in implementation outcomes in different settings. When designing an intervention, those leading future improvement programmes should consider how it sits in relation to these three contextual levels and the interactions that may occur between them.

Identifiants

pubmed: 36828659
pii: bmjopen-2022-066303
doi: 10.1136/bmjopen-2022-066303
pmc: PMC9972449
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e066303

Subventions

Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Osteoarthritis Cartilage. 2015 Apr;23(4):594-600
pubmed: 25579802
BMJ. 2019 Jul 3;366:l4496
pubmed: 31270069
BMJ Qual Saf. 2012 Oct;21(10):876-84
pubmed: 22543475
BMJ Open. 2022 Jun 16;12(6):e058316
pubmed: 35710256
BMJ. 2021 Feb 9;372:n339
pubmed: 33563590
Orthop Clin North Am. 2020 Apr;51(2):169-176
pubmed: 32138855
Orthop Rev (Pavia). 2020 Nov 24;12(3):8526
pubmed: 33312485
BMC Health Serv Res. 2017 Jan 23;17(1):71
pubmed: 28115018
Perspect Med Educ. 2019 Dec;8(6):360-364
pubmed: 31758490

Auteurs

Fiona Aspinal (F)

Department of Applied Health Research, University College London, London, UK f.aspinal@ucl.ac.uk.

Jean Ledger (J)

Department of Applied Health Research, University College London, London, UK.

Sarah Jasim (S)

Care Policy and Evaluation Centre, The London School of Economics and Political Science, London, UK.

Raj Mehta (R)

NIHR ARC North Thames Research Advisory Panel, Department of Applied Health Research, University College London, London, UK.

Rosalind Raine (R)

Department of Applied Health Research, University College London, London, UK.

Naomi J Fulop (NJ)

Department of Applied Health Research, University College London, London, UK.

Helen Barratt (H)

Department of Applied Health Research, University College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH